RhumbLine Advisers’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Buy
232,550
+24,191
+12% +$193K ﹤0.01% 1836
2025
Q4
$1.26M Sell
208,359
-18,440
-8% -$110K ﹤0.01% 2115
2025
Q3
$1.3M Sell
226,799
-2,150
-0.9% -$11K ﹤0.01% 2114
2025
Q2
$1.15M Buy
228,949
+2,300
+1% +$12.3K ﹤0.01% 2171
2025
Q1
$1.47M Sell
226,649
-10,032
-4% -$89.2K ﹤0.01% 1972
2024
Q4
$1.74M Buy
236,681
+1,288
+0.5% +$10.2K ﹤0.01% 1964
2024
Q3
$1.76M Sell
235,393
-3,111
-1% -$27K ﹤0.01% 1979
2024
Q2
$2.12M Buy
238,504
+9,817
+4% +$94.1K ﹤0.01% 1852
2024
Q1
$2.32M Sell
228,687
-46,771
-17% -$476K ﹤0.01% 1833
2023
Q4
$2.77M Buy
275,458
+13,471
+5% +$123K ﹤0.01% 1741
2023
Q3
$2.45M Buy
261,987
+14,374
+6% +$205K ﹤0.01% 1758
2023
Q2
$6.07M Buy
247,613
+12,225
+5% +$307K 0.01% 1267
2023
Q1
$5.48M Buy
235,388
+14,666
+7% +$375K 0.01% 1261
2022
Q4
$5.59M Sell
220,722
-1,645
-0.7% -$40.3K 0.01% 1220
2022
Q3
$4.29M Buy
222,367
+7,561
+4% +$192K 0.01% 1329
2022
Q2
$5.47M Buy
214,806
+150,037
+232% +$3.5M 0.01% 1194
2022
Q1
$1.67M Buy
64,769
+915
+1% +$27.1K ﹤0.01% 1906
2021
Q4
$2.67M Sell
63,854
-480
-0.7% -$18.8K ﹤0.01% 1727
2021
Q3
$2.8M Buy
64,334
+1,383
+2% +$59.9K ﹤0.01% 1702
2021
Q2
$2.98M Buy
62,951
+2,566
+4% +$117K ﹤0.01% 1736
2021
Q1
$3.1M Sell
60,385
-5,050
-8% -$272K ﹤0.01% 1676
2020
Q4
$1.75M Buy
65,435
+4,307
+7% +$140K ﹤0.01% 1914
2020
Q3
$2.1M Sell
61,128
-7,679
-11% -$331K ﹤0.01% 1657
2020
Q2
$2.82M Buy
68,807
+58,253
+552% +$1.96M ﹤0.01% 1539
2020
Q1
$362K Buy
+10,554
New +$284K ﹤0.01% 2314

Other funds holding VIR